证券日报网讯 12月11日，瑞普生物在互动平台回答投资者提问时表示，截至2025年12月10日，公司股 东总户数约2.5万户。 （文章来源：证券日报） ...

宠物食品 行业增长动力发生根本性转变——从单纯依赖宠物数量增长，转向以"宠均消费提升"为核心驱动力。海 外市场增量不断，国产品牌认可度持续提升，龙头企业成长持续兑现。 投资建议与投资标的 投资建议：（1）生猪养殖板块，优质公司持续盈利和分红率提升依然是推动板块长期业绩和估值提升 的核心驱动；近期政策与市场合力推动生猪养殖行业产能去化，助力未来板块业绩长期提升，相关标 的：牧原股份、新希望、温氏股份、神农集团、巨星农牧等。（2）禽板块：产能缓增，价格有望维持 低波动，关注品种间节奏差异。中期黄鸡价格仍可观，远端引种受阻影响下，白鸡苗与肉鸡价格有望上 行，相关标的：圣农发展、益生股份、立华股份。（3）后周期板块，生猪存栏量回升提振饲料、动保 需求，若本轮生猪去产能顺畅，产业链利润有望逐步向下游传导，驱动动保板块上行，相关标的：海大 集团、瑞普生物等。（4）种植链，当前粮价上行趋势已确立，种植与种业基本面向好，大种植投资机 会凸显，相关标的：苏垦农发、北大荒、海南橡胶、隆平高科、荃银高科等。（5）宠物板块，宠食行 业正处于增量、提价逻辑持续落地的阶段，海外市场增量不断，国产品牌认可度持续提升，龙头企业成 长持续兑现 ...

Investment Recommendations - The pig farming sector is currently facing losses for both fat and piglet sales, indicating conditions for capacity reduction. The industry is expected to accelerate capacity reduction, presenting a left-side layout opportunity for the pig farming sector. A price turning point is anticipated in mid-2026 [16][20][34] - Major pig farming companies recommended include Wens Foodstuffs Group and Muyuan Foods, with attention to Dekang Agriculture and New Hope. Companies with potential for operational turnaround include Zhengbang Technology, while smaller farming enterprises to watch include Tiankang Biological, Shennong Group, and Tangrenshen [16][34] Pig Industry Analysis - In 2025, the pig price fell below the cost line, leading to overall industry losses. By November, the average loss per self-breeding pig was 122 CNY per head, with an estimated annual profit of 30-80 CNY per head [20][23] - The industry is experiencing a significant reduction in breeding sow inventory, with a decrease to 39.9 million heads by October 2025, down 1.1% month-on-month and 2.1% year-on-year [28][36] Dairy Industry Analysis - The raw milk price continued to decline in 2025, leading to a reduction in dairy cow inventory. As the supply-demand balance improves, raw milk prices are expected to rise in 2026-2027 [16][18] - The beef supply is also entering a contraction phase, with expectations for beef prices to rise in 2026, enhancing the performance elasticity of livestock companies [16][18] Feed Industry Analysis - The feed sector is expected to see stable water aquaculture production in 2026, while demand for livestock feed is projected to decline due to reduced breeding capacity. Domestic feed leaders are positioned to benefit from overseas expansion opportunities [17][18] - The global feed industry is undergoing structural changes, providing opportunities for Chinese feed companies to expand internationally [17] Animal Health Industry Analysis - The animal health sector faces intensified competition, with traditional vaccine product margins declining. Companies are shifting towards multi-business models, including pet health products, to open new growth avenues [17][18] Pet Food Industry Analysis - The pet food market is showing signs of consolidation, with leading companies like Guai Bao Pet and Zhongchong Co. performing well. The long-term growth logic for the industry remains strong, supported by the rise of domestic brands [17][18] - Companies are also expanding their global production capabilities to mitigate trade friction impacts [17] Crop Industry Analysis - Corn prices are expected to rebound in 2025, with a potential strong performance in 2026. The seed industry is currently in a phase of inventory reduction, with opportunities arising from transgenic innovations and industry consolidation [18][19]

Core Insights - The animal health sector experienced a decline of 0.31% on December 10, with *ST Lvkang leading the drop [1] - The Shanghai Composite Index closed at 3900.5, down 0.23%, while the Shenzhen Component Index rose by 0.29% to 13316.42 [1] Stock Performance - The following stocks in the animal health sector showed varied performance: - **Biological Shares (600201)**: Closed at 14.53, up 1.18% with a trading volume of 395,300 shares and a turnover of 560 million yuan [1] - **Ruipu Biological (300119)**: Closed at 19.24, up 0.79% with a trading volume of 26,900 shares and a turnover of 51.56 million yuan [1] - **Xianfeng Holdings (002141)**: Closed at 3.82, up 0.53% with a trading volume of 177,700 shares and a turnover of 67.70 million yuan [1] - **Qudongli (920275)**: Closed at 8.71, up 0.23% with a trading volume of 9,815 shares and a turnover of 8.47 million yuan [1] - **Jinhe Biological (002688)**: Closed at 6.05, down 0.17% with a trading volume of 67,700 shares and a turnover of 40.90 million yuan [1] - **Hui Sheng Biological (300871)**: Closed at 19.24, down 0.52% with a trading volume of 23,700 shares and a turnover of 45.48 million yuan [1] - **Dayu Biological (920970)**: Closed at 7.70, down 0.65% with a trading volume of 11,700 shares and a turnover of 892,880 yuan [1] - **KQ Biological (688526)**: Closed at 15.36, down 0.65% with a trading volume of 17,600 shares and a turnover of 26.94 million yuan [1] - **Placo (603566)**: Closed at 12.95, down 0.69% with a trading volume of 27,200 shares and a turnover of 35.32 million yuan [1] - **Shenlian Biological (688098)**: Closed at 8.96, down 1.10% with a trading volume of 31,800 shares and a turnover of 28.66 million yuan [1] Capital Flow - On the same day, the animal health sector saw a net outflow of 13.98 million yuan from institutional investors and 18.34 million yuan from retail investors, while individual investors contributed a net inflow of 32.32 million yuan [3]

Group 1 - The core viewpoint is that the pig farming industry is experiencing accelerated capacity reduction due to weak prices and policy-driven factors, with current prices for fat pigs around 11 yuan/kg and weaned piglets at approximately 200 yuan/head, leading to widespread losses in the industry [1][2] - Historical experience suggests that when fat pig and piglet prices are at low levels, the industry is likely to initiate market-driven capacity reduction, which is expected to support long-term price increases for pigs [1][2] - The current trend shows a continued reduction in the breeding sow population, with a slight decrease of 0.14% reported by one third-party agency, indicating that large-scale farms are primarily eliminating inefficient capacity while smallholders are exiting the market [2] Group 2 - Investment recommendations include a positive outlook on the pig farming sector, driven by policy and market forces that promote capacity reduction, which is expected to enhance long-term performance for related companies such as Muyuan Foods, Wens Foodstuff Group, and Shennong Group [4] - The post-cycle sector is anticipated to benefit from a rebound in pig inventory, which will boost demand for feed and animal health products, with potential profit transmission down the supply chain, highlighting companies like Haida Group and Reap Bio [4] - In the planting sector, the upward trend in grain prices is established, indicating favorable fundamentals for planting and seed industries, with investment opportunities in companies like Suqian Agricultural Development and Beidahuang [4]

瑞普生物（300119.SZ）12月9日在投资者互动平台表示，投资者您好，上述相关消息不属实，公司目前 无该款产品，相关领域处于研发布局阶段，请以官方公告为准。感谢您的关注！ （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：网上流传说：瑞普生物有一款针对犬肥大细胞瘤的 MRNA肿瘤疫苗在2024年就已经上市，并于2025年已进入了瑞派、瑞鹏的连锁宠物医院采购体系，这则 消息请问是真的还是假的？ ...

Core Insights - The report maintains a positive outlook on the agricultural sector, particularly in the livestock and pet industries, while highlighting ongoing challenges in pig farming due to supply pressures and price adjustments [2][5][9]. Livestock Industry Overview - Pig farming is experiencing downward price adjustments due to increased supply from smallholders and insufficient demand for cured products, leading to a supply-demand struggle [9][18]. - The number of breeding sows decreased by 0.38% in November, indicating a potential acceleration in capacity reduction [21][9]. - As of December 4, the average price for market pigs was 11.30 CNY/kg, reflecting a week-on-week decline of 1.57% [32][33]. - The profitability of pig farming remains negative, with losses of 167.69 CNY per head for self-bred pigs and 259.39 CNY per head for purchased piglets reported [39][42]. Poultry Industry Insights - The poultry sector is seeing a rise in white chicken prices, with an average price of 7.27 CNY/kg as of December 5, up 1.11% week-on-week [40][44]. - The ongoing outbreaks of avian influenza in overseas markets are expected to benefit the white feather chicken industry in the medium to long term [40][41]. Animal Health Sector - The animal health industry is under pressure due to a decline in demand linked to the overall losses in pig farming, with significant year-on-year decreases in vaccine approvals [50]. - However, the development of new vaccines, including progress in African swine fever vaccine trials, may provide a boost to the sector [50]. Seed Industry Trends - The prices of key agricultural commodities such as wheat, corn, and soybean have shown slight increases, with wheat prices at 2515 CNY/ton, corn at 2357 CNY/ton, and soybean meal at 3111 CNY/ton as of December 5 [53][55]. - The USDA's November report indicates a decrease in global corn and soybean stocks, which may impact future pricing and availability [54][57]. Pet Industry Developments - The pet food export market faced a decline, with October exports amounting to 772 million CNY, down 15.9% year-on-year [58][60]. - Domestic sales of pet food are growing rapidly, with e-commerce sales in October increasing by 19% year-on-year, driven by strong performances from local brands [61][62]. - The Double Eleven shopping festival saw significant sales growth for domestic pet brands, indicating a shift towards local products in the market [62].

Core Insights - The animal health sector experienced a rise of 1.81% on December 8, with BioShares leading the gains [1] - The Shanghai Composite Index closed at 3924.08, up 0.54%, while the Shenzhen Component Index closed at 13329.99, up 1.39% [1] Stock Performance - BioShares (600201) closed at 14.39, with a significant increase of 7.39% and a trading volume of 717,500 shares, amounting to a turnover of 1.014 billion yuan [1] - Other notable stocks included: - Zhongmu Co. (600195) at 8.09, up 1.25% [1] - Deyu Bio (920970) at 7.88, up 0.90% [1] - Yongshun Bio (920729) at 8.85, up 0.80% [1] - Ruipu Bio (300119) at 19.37, up 0.73% [1] Capital Flow Analysis - The animal health sector saw a net outflow of 27.984 million yuan from institutional investors, while retail investors contributed a net inflow of 4.809 million yuan [2] - The main capital flow for BioShares (600201) showed a net inflow of 26.5384 million yuan from institutional investors, despite a net outflow of 35.9123 million yuan from retail investors [3] - Other stocks like *ST Lvkang (002868) and Huisheng Bio (300871) also experienced varied capital flows, with institutional and retail investors showing different trends [3]

证券之星消息，12月5日动物保健板块较上一交易日上涨1.45%，生物股份领涨。当日上证指数报收于 3902.81，上涨0.7%。深证成指报收于13147.68，上涨1.08%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002868 | *ST绿康 | 36.64 | -0.57% | 3.37万 | 1.22亿 | | 300119 | 瑞普生物 | 19.23 | -0.21% | 4.17万 | 8014.54万 | | 920275 | 驱动力 | 8.93 | 0.00% | 2.17万 | 1895.31万 | | 688526 | 科前生物 | 15.55 | 0.32% | 1.20万 | 1862.15万 | | 603566 | 普莱柯 | 13.08 | 0.46% | 2.52万 | 3283.78万 | | 002141 | 贤丰控股 | 3.94 | 0.51% | 21.89万 | 8580.68万 | | 688098 | 申联生 ...

证券日报网讯12月2日，瑞普生物（300119）在互动平台回答投资者提问时表示，截至2025年11月28 日，公司股东总户数约2.5万户。 ...